Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Combination therapy with PKC-412, 5-FU and leucovorin evaluated in phase I trial

Oct. 25, 2001

Cell Therapeutics and Chugai establish agreement to develop cancer product

Oct. 25, 2001

Minimal toxicity seen in phase I studies of new camptothecin conjugate

Oct. 25, 2001

U.S. clinical trials of new polyamine drug SL-11047 will now begin

Oct. 25, 2001

Clinical testing of NIK-333 commences

Oct. 25, 2001

Phase I/II trial results for CG-7870 discussed at ECCO 11

Oct. 25, 2001

Tipifarnib-based antitumor combinations extensively patented by Janssen

Oct. 24, 2001

Zometa will receive priority review for treatment of bone metastases

Oct. 24, 2001

SQN-400, a new photosensitizer, evaluated in patients with liver metatases from colorectal cancer

Oct. 24, 2001

Topical DNA repair enzyme-containing formulation prevents skin cancer

Oct. 24, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...